SignatureFD’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

SignatureFD’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-175	Closed	-$21.3K	–	3222
2023 Q4	$21.3K	Buy	+175	New	+$13.4K	﹤0.01%	1893
2019 Q2	–	Sell	-19	Closed	-$22K	–	2111
2019 Q1	$22K	Hold	19	–	–	﹤0.01%	1154
2018 Q4	$12K	Buy	+19	New	+$19.9K	﹤0.01%	1304

Other funds holding LABU

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TAA

TB Alternative Assets Grand Cayman, Cayman Islands $623M AUM 154.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

SignatureFD's LABU Position: Q1 2024 in Review

SignatureFD sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2024, closing a stake of 175 shares — an estimated $21.3K sold.

SignatureFD first reported a position in LABU in Q4 2018 and held it in 3 quarters. The position peaked at $22K in Q1 2019. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2024.

SignatureFD reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2024 after selling out during the quarter.
SignatureFD sold 175 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2024, an estimated $21.3K.
SignatureFD first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2018 and held it in 3 quarters.
SignatureFD's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $22K in Q1 2019.
33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2024.

Based on SignatureFD's 13F filing for Q1 2024, filed 3 May 2024.